Dan Li

Nih

[Dan Li @danli_502]

It's really my honorable to give a presentation at #ILCA24! I'd like to appreciate my mentor Dr. Mitchell Ho @MitchellHo for his guidance and support! Learn a lot from Big guys in the field.

[Mitchell Ho, PhD @MitchellHo]

Proud to listen to Dr Dan Li @danli_502 present our work on engineering T cells to target GPC3 in HCC at #ILCA24. @NCIResearchCtr @IRPatNIH @NCI_Training

[Mitchell Ho, PhD @MitchellHo]

Very proud of Dr Dan li @danli_502, who received “Outstanding Postdoctoral Fellow Award” from Dr. Douglas R. Lowy @theNCI. She presented our new development of camel nanobodies and CAR-T cells targeting B7-H3 for treating cancer at CCR FYI Colloquium @NCI_Training @NCIResearchCtr

[Mitchell Ho, PhD @MitchellHo]

Dr Dan Li @danli_502 @NCIResearchCtr @EurekaThera is presenting our poster on newly engineered CAR-T cells based on gamma/delta TCR platform targeting glypicans in solid tumors
@AACR #AACR24

[Dan Li @danli_502]

Excited to share our work on the preclinical testing of nanobody-based B7-H3 CAR-T cells to treat solid tumors! This is my first Nature Communications! A fantastic teamwork! Thank you Dr. @MitchellHo https://t.co/o300pKfD3W

[Mitchell Ho, PhD @MitchellHo]

Our new paper is out. We used dromedary camel VHH phage libraries to identify nanobodies against novel epitopes of B7-H3 to create CAR-T cells showing unexpected anti-tumor activity in large tumor models. ⁦@NatureComms⁩ ⁦@NCIResearchCtr⁩⁦ https://t.co/s4jlVHiJJb

[Nature Communications @NatureComms]

Development and optimization of CAR T cells targeting glypican-1 for pancreatic cancer therapy.
https://t.co/MDU6ZWReaL #CancerResearch @natrescancer @MitchellHo @NanLizea @theNCI @NCIResearchCtr @IRPatNIH

[Mitchell Ho, PhD @MitchellHo]

It is such an honor and privilege to work with a group of talented and dedicated trainees, colleagues and collaborators @NCIResearchCtr @IRPatNIH to develop new cancer therapeutic targets. @NanLizea @danli_502 @pan_jiajia @gerard_hoeltzel @CachauRaul

[Mitchell Ho, PhD @MitchellHo]

At #AACR22 Nan Li @NanLizea and Dan Li @danli_502 presented work from our lab on #nanobody-based CAR T cells targeting GPC1 in #PancreaticCancer and PD-L1 @NCIResearchCtr

[Jeffrey Millman @JeffreyRMillman]

The tale of being a new PI, as told in a live action performance #AcademicTwitter #AcademicChatter #phdchat

[Mitchell Ho, PhD @MitchellHo]

Finally here is the story of the generation of new CAR T cell therapy for treating liver cancer. Honored to have led a multidisciplinary team that developed this amazing molecule. @AGA_Gastro @NCIResearchCtr @theNCI @NCITechTransfer @AmerGastroAssn @liver_cancer

[Dan Li @danli_502]

Very nice work in the Ho lab!

[NIH Intramural @IRPatNIH]

#NIH @theNCI @NCIResearchCtr's Dr. Mitchell Ho is scouring the animal kingdom in search of mini-antibodies called nanobodies that might help combat #COVID19. https://t.co/SZr0JIrblR